Whitepaper , Bioanalysis

Bioanalytical services to accelerate drug development


Highly sensitive bioanalytical techniques enable the identification and quantification of analytes such as small molecules, peptides, proteins, nucleic acids, and metabolites, all from very small volumes of biological samples. Delivering rapid bioanalytical data is critical to meeting milestones in drug development. From drug discovery through to preclinical and clinical studies, understanding drug exposure, safety, and metabolism is essential in accelerating drugs to clinic and commercialization.

At Quotient, we are experts in the development, validation, and application of bioanalytical assays. Our industry-leading bioanalytical team has more than 40 years of experience in supporting all stages of drug development, from early preclinical through to FIH, and onwards to Phase II and III patient studies.

We pride ourselves on our relationships with customers, and the speed with which we report our bioanalytical data. Over the past 5 years, we have supported bioanalysis projects for almost 100 customers globally, ranging from virtual companies and biotech to mid-sized and large Pharma. To date, we have developed and validated more than 400 bioanalytical methods.

Contact us to discuss how we can help you gain a clear understanding of the biological fate of your molecules and accelerate your development programs.